# FDA recall Z-1773-2019

> **Cardiocommand Inc.** · Class III · device recall initiated 2019-05-10.

## Product

CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia

## Reason for recall

Possible corrosion of the battery contact(s).

## Distribution

US Nationwide distribution in the states of CT, VW, OH, IL, DE.

## Key facts

- **Recall number:** Z-1773-2019
- **Recalling firm:** Cardiocommand Inc.
- **Classification:** Class III
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2019-05-10
- **Report date:** 2019-06-19
- **Termination date:** 2021-04-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Tampa, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1773-2019

## Citation

> AI Analytics. FDA recall Z-1773-2019. Retrieved 2026-06-05 from https://api.ai-analytics.org/recall/Z-1773-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*